Diligence memo · auto-generated · as of July 2, 2026
CorneaGen Inc.
CorneaGen Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
CorneaGen Inc. operates in Other Health Care, based in SEATTLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
CorneaGen Inc. has raised $17M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $10M on 2016-10-07.
Most recent recorded round closed around 2018-05-05.
Valuation (modeled)modeled
Provath models CorneaGen Inc. at approximately $40M (range $2.6M–$219M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.33× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 8.2 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 82% of Other Health Care peers (5377 compared).
Modeled value ranks above 64% of those peers.
Closest niche peers: HemoSonics, LLC, Airxpanders Inc, Mercator Medsystems Inc, Simple Contacts Inc., AVG Holdings, Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.